PreprintCited by 10Heat shock proteins researchAlzheimer's disease research and treatmentsBiochemical and Structural Characterization

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

The bacterial chaperone CsgC inhibits functional amyloid CsgA formation by promoting the intrinsically disordered pre-nuclear state

Open access

Preprint — published as 10.1016/j.jbc.2025.110217 · Paper page

Abstract

E. coli assembles a functional amyloid called curli during biofilm formation. The major curlin subunit is the CsgA protein, which adopts a beta-sheet rich fold upon fibrillization. The chaperone-like protein CsgC inhibits CsgA amyloid formation. CsgA undergoes a 3-stage aggregation process: an initial lag phase where beta-rich nuclei form, an exponential elongation phase, and a plateau phase. It is currently not known if CsgC inhibits amyloid formation by inhibiting formation of a pre-fibril nucleus, or if CsgC inhibits a later stage of amyloid formation by blocking monomer addition. Here, CsgC homologs from C. youngae , C. davisae , and H. alvei were purified and characterized for their ability to interrogate CsgA amyloid formation. Each of the CsgC homologs prolonged the lag phase of E. coli CsgA amyloid formation similar to E. coli CsgC. Additionally, we found E. coli CsgC interacted transiently and weakly with a monomeric, pre-nucleus species of CsgA which delayed amyloid formation. A transient CsgC-CsgA heterodimer was observed using ion mobility-mass spectrometry. When CsgC was added to actively polymerizing CsgA, exponential growth commonly associated with nucleation-dependent amyloid formation was lost. Adding preformed CsgA seeds did not rescue exponential growth, indicating that CsgC also has inhibitory activity during fibril elongation. Indeed, CsgC interacted strongly with CsgA fibers, suggesting the interaction between CsgC and CsgA fibers can slow new fiber growth. CsgC displays unique inhibitory activity at multiple stages of amyloid formation. CsgC acts as an energy-independent chaperone that transiently interacts with prefibrillar CsgA and an amyloid fiber.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2025.03.21.644623

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 53

  1. 10.1146/annurev-biochem-061516-045115 · DOI · Paper page
  2. 10.1146/annurev.biochem.75.101304.123901 · DOI
  3. 2002, Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases, Nature, 2002, 6880
  4. 2007, Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid β-peptide, Nature Reviews Molecular Cell Biology, 2007, 2
  5. 10.3390/microorganisms8121951 · DOI
  6. 10.1126/science.1067484 · DOI
  7. 10.4161/pri.4.4.13676 · DOI
  8. 10.1016/j.jmb.2018.07.007 · DOI
  9. 10.1111/j.1365-2958.2011.07706.x · DOI
  10. 10.1073/pnas.0703310104 · DOI
  11. 10.1073/pnas.0812143106 · DOI
  12. 10.1016/j.molcel.2014.12.025 · DOI
  13. 10.1016/j.str.2011.05.015 · DOI
  14. 10.1038/srep24656 · DOI
  15. 10.1016/S0959-440X(99)00049-4 · DOI
  16. 10.1016/j.tim.2015.07.010 · DOI
  17. 10.1016/j.molcel.2014.12.025 · DOI
  18. 10.1039/D1SC05790A · DOI
  19. 10.1074/jbc.M112.383737 · DOI
  20. 10.1107/S0907444910042022 · DOI
  21. 2018, Bacterial amyloids. in Methods in Molecular Biology, Humana Press Inc, 1779, 267
  22. 10.3389/fmicb.2020.00944 · DOI
  23. 10.1371/journal.pone.0025157 · DOI
  24. 10.1039/C4CP05563B · DOI
  25. 10.1371/journal.pone.0051274 · DOI
  26. 2016, Molecular mechanisms of protein aggregation from global fitting of kinetic models, Nature Protocols, 2016, 2
  27. 10.1371/JOURNAL.PBIO.0020321 · DOI
  28. 10.1016/j.abb.2007.05.015 · DOI
  29. 10.1021/bi200967c · DOI
  30. 10.1074/jbc.M609228200 · DOI
  31. 10.1021/cr068107d · DOI
  32. 10.1021/ACS.CHEMREV.1C00212/ASSET/IMAGES/LARGE/CR1C00212_0030.JPEG · DOI
  33. 10.1021/ac504720m · DOI
  34. 10.1002/pmic.201800060 · DOI · Paper page
  35. 10.1110/ps.051762406 · DOI
  36. 10.1073/pnas.1220326110 · DOI
  37. 10.1039/c3cp50721a · DOI
  38. 2011, Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation, Nature, 2011, 7354
  39. 10.1021/bi8005797 · DOI
  40. 10.3390/IJMS19092677 · DOI
  41. 10.1038/nchembio.2413 · DOI
  42. Gharibyan, A. L. , Jayaweera, S. W. , Lehmann, M. , Anan, I. , and Olofsson, A . (2022) Endogenous Human Proteins Interfering with Amyloid Formation. Biomolecules 2022, Vol. 12, Page 446. 12, 446 · DOI
  43. 2016, Kinetic analysis reveals the diversity of microscopic mechanisms through which molecular chaperones suppress amyloid formation, Nature Communications, 2016, 1
  44. 10.1016/j.tim.2015.07.010 · DOI
  45. 10.1128/MBIO.02279-18/SUPPL_FILE/MBIO.02279-18-S0003.PDF · DOI
  46. 10.1110/ps.073164107 · DOI
  47. 10.1002/pro.5178 · DOI
  48. 10.1126/SCIADV.ABN6831 · DOI
  49. 10.1016/B978-0-443-21809-5.00006-5 · DOI
  50. 10.1073/pnas.181342398 · DOI
  51. 10.1093/nar/gki198 · DOI
  52. 10.1093/bioinformatics/9.6.745 · DOI
  53. 10.1016/0022-2836(80)90283-1 · DOI

Metadata

Authors
Balistreri, A., Kolli, D., Jayaweera, S. W., Lundahl, D., Han, Y., Kalcec, L., Goetzler, E., Alessio, R., Ruotolo, B., Olofsson, A., & Chapman, M. R.
Affiliations
  • University of Michigan (US)
  • Umeå University (SE)
Corresponding author
Chapman, Matthew R.
Venue
Journal of Biological Chemistry
Publisher
openRxiv
Published
2025-03-21
Volume
301
Issue
6
Pages
110217-110217
ISSN
0021-9258 (ISSN-L)
OpenAlex
W4410200313
Cited by
10
References
1
Citations by year
2026: 9 · 2025: 1
FWCI
3.01
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (submittedVersion)
  • Diva portal (Dalarna University Library) (submittedVersion, other-oa)
Funders
  • Foundation for the National Institutes of Health (R01 GM095832, T32 AI007528, R01GM118651, R21 AI137535)
  • National Institutes of Health (AI007528, GM118651)
  • National Institute of General Medical Sciences (R01GM095832, R01GM118651)
  • National Institute of Allergy and Infectious Diseases (R21AI137535, T32AI007528)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Structural Characterization
Keywords
CsgA, curli, functional amyloids, amyloid formation inhibition, molecular chaperones, nucleation, fibril elongation, Escherichia coli biofilm, heterodimer, Citrobacter youngae, Cedecea davisae, Hafnia alvei

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review